Innovex International (INVX) executive sells 20,000 shares at $25

Rhea-AI Filing Summary

Innovex International, Inc. executive Mark Reddout, President of North America, reported selling 20,000 shares of common stock on January 14, 2026 at $25 per share. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 10, 2025, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). After this transaction, he directly beneficially owned 129,436 shares of Innovex International common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reddout Mark

(Last) (First) (Middle)

C/O INNOVEX INTERNATIONAL, INC.

19120 KENSWICK DRIVE

(Street)

HUMBLE TX 77338

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Innovex International, Inc. [ INVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President of North America

3. Date of Earliest Transaction (Month/Day/Year)
01/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/14/2026		S		20,000(1)	D	$25(2)	129,436	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sales pursuant to a Rule 10b5-1 plan adopted on March 10, 2025.

2. All shares were sold at the price in column 4.

	/s/ Matt Steinheider, Attorney-in-Fact for Mark Reddout	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the insider involved in the Innovex International (INVX) Form 4 filing?

The filing reports a transaction by Mark Reddout, who serves as President of North America at Innovex International, Inc..

What transaction did Mark Reddout report for Innovex International (INVX)?

He reported the sale of 20,000 shares of Innovex International common stock on January 14, 2026 with transaction code S (sale).

At what price were the Innovex International (INVX) shares sold in this Form 4?

All 20,000 shares were sold at $25 per share, as noted in the price column and confirmed by the filing’s explanation of responses.

How many Innovex International (INVX) shares does Mark Reddout own after the reported sale?

Following the reported transaction, Mark Reddout beneficially owned 129,436 shares of Innovex International common stock, held directly.

Was the Innovex International (INVX) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the sales were made pursuant to a Rule 10b5-1 plan adopted on March 10, 2025, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Is this Innovex International (INVX) Form 4 filed for one or multiple reporting persons?

The document indicates that the Form is filed by one reporting person, namely Mark Reddout.